With a serious decline in only 1 in 10 drugs successfully passing phase II/III of clinical trials, there is increasing pressure to bring drugs quickly into the market and reduce the cost of drug development. This conference offers the perfect platform to hear strategies such as 鈥淪eamless Adaptive Designs鈥� and 鈥淕roup 鈥揝equential Adaptive Designs鈥� which are areas that improve the efficiency of drug development.
This conference will review the drug development process and provide a detailed discussion of how adaptive designs are changing the development process. The main focus of the presentation will be to explore the role of adaptive sample sizing; in particular, why it is important to consider the need to reassess sample sizes during the course of a trial. It is designed for those looking to network and gain the latest knowledge from the academics, industry leaders and regulators.
>>>>Key Presentation Highlights include:
鈥� Understand the objectives of Adaptive Licensing and MAPPs as the 鈥渂reakthrough鈥� designations to accelerate the approval of new medicines.
鈥� Learn how Bayesian Belief Networks can support reliability management and decision making.
鈥� Discover novel techniques in CARA and Seamless Adaptive Designs and Bayesian Bandit models to optimize efficiency in dosefinding strategies.
鈥� Benefit from the talks of industry leaders and CEO鈥檚 in clinical leadership and how real world evidence can improve adaptive.
This conference will review the drug development process and provide a detailed discussion of how adaptive designs are changing the development process. The main focus of the presentation will be to explore the role of adaptive sample sizing; in particular, why it is important to consider the need to reassess sample sizes during the course of a trial. It is designed for those looking to network and gain the latest knowledge from the academics, industry leaders and regulators.
>>>>Key Presentation Highlights include:
鈥� Understand the objectives of Adaptive Licensing and MAPPs as the 鈥渂reakthrough鈥� designations to accelerate the approval of new medicines.
鈥� Learn how Bayesian Belief Networks can support reliability management and decision making.
鈥� Discover novel techniques in CARA and Seamless Adaptive Designs and Bayesian Bandit models to optimize efficiency in dosefinding strategies.
鈥� Benefit from the talks of industry leaders and CEO鈥檚 in clinical leadership and how real world evidence can improve adaptive.
